(firstQuint)Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis.

 1.

 To assess the efficacy of FK506 combined with MMF vs intravenous cyclophosphamide (CTX) pulses in treatment of class III,IV,V,III+Vand IV+V Lupus Nephritis (LN).

 2.

 To investigate the safety and tolerability of FK506 combined with MMF vs intravenous CTX pulses in the treatment of class III,IV,V,III+Vand IV+V LN.

.

 Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis@highlight

The purpose of this study is to assess the efficacy and safety of multi-target therapy in the treatment of class III,IV,V,III+Vand IV+V lupus nephritis.

